Valuation APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 10/07/2026			5-day change	1st Jan Change
1,715.00 ^KRW	-0.23%		+0.06%	-65.70%

07-01	Aprogen Biologics Inc. announced that it has received KRW 50.8 billion in funding from APTOCROM Inc.	CI
05-26	Aprogen Biologics Inc. announced that it expects to receive KRW 50.8 billion in funding from APTOCROM Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	132,471	125,151	66,950	51,548	104,593	55,189
Change	-	-5.53%	-46.5%	-23.01%	102.9%	-47.23%
Enterprise Value (EV) ¹	101,306	69,004	-14,380	55,057	79,526	37,996
Change	-	-31.89%	-120.84%	482.87%	44.44%	-52.22%
P/E	12x	47.2x	-11.9x	24x	-2.12x	-9.5x
PBR	0.57x	0.56x	0.34x	0.31x	0.35x	0.18x
PEG	-	-0.6x	0x	-0x	0x	0.1x
Capitalization / Revenue	12.8x	14.9x	6.98x	3.22x	6.38x	5.63x
EV / Revenue	9.82x	8.2x	-1.5x	3.44x	4.85x	3.87x
EV / EBITDA	4,671x	-31.8x	1.22x	-2.69x	83.9x	-2.32x
EV / EBIT	-270x	-26.8x	1.19x	-2.62x	154x	-2.27x
EV / FCF	-1.98x	5.77x	-0.46x	13.1x	-32.9x	-1.9x
FCF Yield	-50.6%	17.3%	-216%	7.65%	-3.04%	-52.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	6,200	1,484	-3,140	648.5	-4,924	-526.5
Distribution rate	-	-	-	-	-	-
Net sales ¹	10,319	8,416	9,598	16,007	16,400	9,807
EBITDA ¹	21.69	-2,167	-11,810	-20,454	947.7	-16,372
EBIT ¹	-375.2	-2,579	-12,099	-21,004	517.3	-16,737
Net income ¹	11,084	2,650	-5,607	4,304	-28,094	-5,559
Net Debt ¹	-31,165	-56,147	-81,330	3,509	-25,067	-17,192
Reference price ²	74,200.00	70,100.00	37,500.00	15,580.00	10,420.00	5,000.00
Nbr of stocks (in thousands)	1,785	1,785	1,785	3,309	10,038	11,038
Announcement Date	3/15/21 A	3/14/22 A	3/17/23 A	3/13/24 A	3/14/25 A	3/20/26 A

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
APTOCROM INC.	-	-	-	-	12.61M
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30.1x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.78x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.81x	5.6x	30.89x	2.5%	161B
Average	16.07x	6.44x	16.43x	2.44%	357.39B
Weighted average by Cap.	23.83x	7.85x	18.15x	2%